Grupo Uriach Integral Contract Services - Expansion rewards for all

With new facilities and individually tailored customer care plans, one Spanish contract manufacturer now offers an improved service range.


Grupo Uriach's new plant in Palau-solità I Plegamans, Barcelona, brings with it an enormous qualitative and quantitative leap in the company's technological and productive capacity. A total area of 30,000m2 is given over to production and research.

The latest advances in industrial construction mean that the plant has a structure that is completely isolated, facilitating rapid and efficient technical interventions from outside without affecting the environmental quality of the production areas and with minimal hold-ups in production processes.

The company's facilities are equipped for the production of tablets, capsules, sugar-coated pills, coated tablets, effervescent tablets, pellets, powders, creams and ointments.

Grupo Uriach offers a comprehensive range of services in accordance with GMP/GLP requirements, which ensure an optimal level of quality in all processes.

Drug development

Operating to full cGMP, Grupo Uriach's team of highly skilled scientists can develop and optimise a formulation to progress drugs to commercial manufacture.

The company recognises the importance of working with clients to reduce the time between drug discovery and commercialisation.

A reliable formulation ensures a client's drug will perform clinically, and assures manufacturability and optimal stability. Services include:

  • Preformulation and drug characterisation
  • Manufacturing process development
  • Process optimisation

Analytical development

The company's analytical services can support all a client's R&D and manufacturing programmes.
With extensive experience in method development for standard analytical and microbiology testing, refinement and validation, Grupo Uriach provides a comprehensive understanding of the physical and chemical properties of drug compounds. Services include:

  • Development and validation of analytical and microbiological methods
  • Cleaning method development and validation
  • Dissolution and drug-release profiling
  • Stability monitoring to ICH guidelines

Manufacturing

Grupo Uriach's facilities allow it to be highly versatile in the development of granules. The pilot plant, with GMP standard, has a fluid bed, planetary granulator, high-speed granulator and one single pot. For the development of new solid formulations, there is an instrumented eccentric compression machine, which allows for the characterisation of mixtures in order to optimise their compression.

Other services include process validation, stability testing, regulatory and quality support, product registration support, customised manufacturing and packaging, and supply chain management.

Long-standing expertise

Grupo Uriach Integral Contract Services is one of the leading pharmaceutical companies in the Spanish and European markets, having been in operation for more than 165 years. The company's constant development during this time has been due to its commitment to evolution, innovation and service.

The company, while meeting its own commercial objectives, is also able to offer a complete service to other companies, based on the development of collaborative projects that can be adapted to the specific needs of each client.

Through a personalised customer-care plan, Grupo Uriach is able to adjust its processes in accordance with client requirements.


Company profile

Founded in the mid-1800s, Grupo Uriach Integral Contract Services is the second-oldest pharmaceutical group in Europe.

Products and Services

Contact Details

Grupo Uriach Integral Contract Services
URL: www.uriach.com

The Barcelona plant is dedicated to production and research.
Make An Enquiry
First Name

Last Name

Email Address

Enquiry


Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.